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Litter size and birth weights are limited by uterine capacity, defined as the ability of the uterus to maintain the
appropriate development of some number of conceptuses. Uterine capacity is the result of the combined effects of
uterine, placental and embryo/fetal function. The number of living conceptuses that the uterus is capable of
supporting is greater during early gestation compared to later gestation. Plots of log fetal weight versus log
placental weight also indicate that fetal weights are less sensitive to reduced placental weight (and therefore
reduced intrauterine space) in early gestation compared to late gestation. However, even in late gestation,
mechanisms still exist that maintain fetal growth when the size of the placenta is reduced. One such mechanism is
likely to be improved development of the folded placental-epithelial/maternal-epithelial bilayer. Fold depth, and
therefore the maternal fetal interactive surface, increases as gestation advances and is greater in placenta from small
fetuses. On the fetal side of the placenta, the epithelial bilayer is embedded in stromal tissue. Glycosaminoglycans
are major components of stroma, including hyaluronan and heparan sulfate. Hyaluronidases and heparanases are
present within placental tissues, and likely play roles in modification of stromal components to facilitate fold
development. Glycosaminoglycans are polymers of forms of glucose (glucosamine, glucuronic acid, iduronic acid)
suggesting that glycosaminoglycan synthesis may compete with the glucose needs of the developing fetus.
Pig conceptuses are fructogenic, such that a substantial portion of glucose transferred from mother to fetus is
converted to fructose. Fructose is an intermediate product in the synthesis of glucosamine from glucose, and
glucosamine is linked to regulation of trophoblast cell proliferation through regulation of mTOR. These findings
suggest a link between glucose, fructose, glucosamine synthesis, GAG production, and placental morphogenesis,
but the details of these interactions remain unclear. In addition, recent placental epithelial transcriptome analysis
identified several glucose, amino acid, lipid, vitamin, mineral and hormone transporter mechanisms within the
placenta. Further elucidation of mechanisms of placental morphogenesis and solute transport could provide clues
to improving nutrient transport to the pig fetus, potentially increasing litter size and piglet birth weights.
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A recent analysis by the National Pork Board indicated
that between 2007 and 2012, the number of piglets born
alive per litter improved by 0.25 piglets per year, while
the number of piglets weaned per litter improved by
only 0.16 piglets per year [1]. This difference translates
into an increase in preweaning mortality of 0.3% per
year, and is a concern not only from a production stand-
point, but also from an animal well-being standpoint.
The increase in the number born alive is likely due to a* Correspondence: jeff.vallet@ars.usda.gov
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unless otherwise stated.combination of improved management and genetic selec-
tion of breeding animals. Although it was not measured in
the study, the disparity between the improvement in the
number of piglets born alive and the number of piglets
weaned is most likely due to the well known depression in
piglet birth weight associated with increased litter size [2].
Reduced birth weights are a primary factor associated with
preweaning mortality [3-5], and may explain the observed
increase in preweaning mortality. Finally, depression of
birth weights with increasing litter size is a manifestation
of limitations on conceptus development that are imposed
by uterine capacity.his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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Uterine capacity has been defined in a variety of ways.
The number of piglets that can be supported by the
uterus during gestation until farrowing if the number of
potential fetuses is not limiting, is a common definition
[6]. This definition includes stillborn piglets, which die
during farrowing, but does not include mummified fe-
tuses, which die at some point during gestation. It does
not fully describe uterine capacity in totality because it
does not include any component reflecting differences in
piglet birth weights. Clearly, a pig uterus that can sup-
port ten 2 kg fetuses has greater uterine capacity than a
pig uterus that can support ten 1 kg fetuses. Finally, in
practice, the independence of uterine capacity from the
number of potential fetuses is also problematic. The re-
lationship between the maximum litter size that can be
maintained by the uterus and the number of potential
embryos is almost certain to be curvilinear. Reports sug-
gest that at moderate intrauterine crowding, litter size
reaches a peak. Significant further crowding beyond this
point reduces the number of viable embryos/fetuses,
probably by reducing the number of embryos able to ob-
tain sufficient uterine space for survival due to intrauter-
ine competition for space among embryos [7].
Studies of intrauterine crowding and uterine capacity
have employed a variety of methods. The most straight-
forward to apply is unilateral hysterectomy-ovariectomy
(UHO) [8]. In this surgical method, one ovary and one
uterine horn are removed. Compensatory ovarian hyper-
trophy results in a normal ovulation rate, with only half
the available uterine space. The intrauterine crowding
that results is relatively moderate and uniform between
pigs compared to that caused by superovulation [9], and
the UHO surgical procedure is simpler and more repro-
ducible than embryo transfer [10]. The surgery can be
done early in life (i.e., before puberty, typically 100 to
160 days of age) and the pig can be allowed to recover,
reducing the interference of the surgery with normal
pregnancy physiology that occurs when uterine ligation
methods are used [11]. Genetic selection also increases
uterine crowding [12], but takes several generations to
accomplish. Litter size in UHO females has been re-
ported to be independent of ovulation rate, and it has
been assumed that the litter size obtained is half the
uterine capacity [8] for that animal. The UHO procedure
has been used successfully to select pigs for uterine cap-
acity [13,14].
Placental efficiency
There have been some approaches to placental efficiency
that have not required an understanding of the under-
lying mechanisms, but their utility has been controver-
sial and limited. One approach, the fetal weight to
placental weight ratio, has been suggested as a broadindicator of placental efficiency [15,16]. An early report
that this ratio could be used to select animals for placen-
tal efficiency, with subsequent improvements in litter
size [17], was not confirmed using more rigorous selec-
tion methods over several generations [18]. Also, litter
size was improved in a line selected for uterine capacity
but selection did not alter the fetal weight to placental
weight ratio and selection for ovulation rate did not alter
litter size but did alter the fetal weight to placental
weight ratio [19]. Although it makes sense that the size
of a fetus supported by a given size of placenta should
reflect placental efficiency, use of the ratio as a measure
of placental efficiency fails to consider the ability of the
fetus and placenta to adjust efficiency as the size of the
placenta is reduced. In other words, if compensatory
mechanisms exist to adjust placental efficiency as the
size of the placenta is reduced, the fetal weight to pla-
cental weight ratio does not measure absolute placental
efficiency for a given conceptus, as would be required to
implement genetic selection. Instead, the fetal weight to
placental weight ratio measures placental efficiency for
that conceptus given the size of the placenta. If that
same conceptus developed a smaller placenta, compen-
satory mechanisms would raise placental efficiency,
which would then be reflected in the fetal weight to pla-
cental weight ratio.
Evidence of compensatory mechanisms for placental
efficiency can be found by examining relationships be-
tween log fetal weight and log placental weight during
gestation [20,21]. Huxley [22] proposed that the slope of
log-log relationships between individual body parts or
between a body part and the entire organism reflects the
relative growth between the two (Figure 1). A slope of 1
indicates proportional growth, greater than 1 indicates
that the y variable grows faster than the x variable, less
than one indicates that the y variable grows more slowly
than the x variable [23]. Extending this concept to the
fetus and placenta, a slope of one indicates a fully pro-
portional relationship, the fetus is proportionally larger
if the placenta is larger. As placental size is reduced,
fetal size is also reduced, and the ratio of the two is
the same (placental efficiency is constant and no com-
pensatory mechanisms are present). A slope less than
one indicates fetal growth is not fully proportional to
the size of the placenta. As placental size is reduced,
fetal size is less affected (placental efficiency increases
suggesting compensatory mechanisms are present).
The slope of the relationship between log fetal weight
and log placental weight increases throughout gesta-
tion, but even in late gestation is still less than one
[21]. Growth of the fetus is not very dependent on
placental size during early gestation, and becomes
more dependent as gestation advances, but is never








Figure 1 Possible allometric relationships between fetal weight and placental weight are illustrated. According to Huxley [22], the
relationship between fetal weight and placental weight can be described with the equation fetal weight = constant × placental weightf/p where f
and p represent growth rates of the fetus and placenta, respectively. Given this relationship, the slope of the linear relationship between log fetal
weight and log placental weight is f/p, the relative growth rates of the two components. The graphs represent (a) untransformed and (b) log
transformed hypothetical relationships where growth is fully proportional (i.e., growth rates are equal; solid line), only 70% of changes in placental
weight are reflected in changes in fetal weight (a fetal sparing effect where fetal growth is relatively insensitive to differences in placental weight;
small dashes), and 130% of changes in placental weight are reflected in changes in fetal weight (fetal growth is highly sensitive to differences in
placental weight; large dashes). In pigs, even during late gestation, the slope of the log fetal weight to log placental weight relationship is less
than one, indicating fetal sparing [21].
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even in late gestation.
Factors affecting placental function
The pig placenta is classified as diffuse epitheliochorial
[24]. This distinguishes it from other livestock species in
that there are no placentomes (making it diffuse), and
both the fetal and maternal epithelial cell layers are
maintained throughout gestation (making it epithelio-
chorial). Numerous factors affect the efficiency of pla-
cental transport of nutrients. Generally, these factors fall
into two broad categories, physical and nutrient specific.Physical factors include maternal and fetal blood flow
(both rates and physical arrangement relative to one an-
other), fetal and maternal interactive surface area, and the
distance between maternal and fetal capillaries. These fac-
tors globally affect the transport of all nutrients. Nutrient
specific factors are as varied as the nutrients transported.
To fully understand placental transport, it is necessary to
fully characterize the contribution of both categories.
The physical structure of the placenta divides into
areolae and interareolar areas [25]. Areolae take up his-
totroph secreted by uterine glands [26,27]. Histotroph
represents nutrient specific transport and will be dealt
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endometrial epithelium layer tightly adhered to a fetal
epithelium layer (trophoblast), which becomes folded be-
ginning about day 30 to 35 of gestation (Figure 2). The
folds become more elaborate and more extensive as ges-
tation advances [20,28]. During mid gestation, the folds
are relatively close to one another. During late gestation,
fetal placental stroma grows into the region between the
folds creating a stromal space between folds, and sec-
ondary folds develop into this space. As this is taking
place, the bilayer separating maternal and fetal capillaries
becomes thinner, to the point that maternal and fetal ca-
pillaries actually indent into, but do not penetrate, the
epithelial cell layers. The indentation of capillaries re-
duces the distance between maternal and fetal capillaries
to as little as 2 microns [28].Figure 2 Schematic showing changes in the pig placental epithelial b
bilayer has a regular appearance and is embedded in placental stroma. The
epithelial cells at the tops (fetus side is up in the figures) of the folds are ta
cubiodal epithelia. By day 105 of gestation (b), the folded bilayer is wider,
surface area. The epithelial cells of the bilayer are thinner to reduce the dis
is expanded to accommodate the secondary folds. The stroma covering th
Fetal and maternal capillaries (not shown) are immediately adjacent to the
countercurrent fashion.Blood flow and angiogenesis of the pig uterus and pla-
centa have received a great deal of attention. Increased
uterine blood flow in response to increased litter size
has been reported, but appears to be limited [29,30].
The fetal weight to placental weight ratio has been re-
ported to be correlated with placental blood vessel dens-
ity in a comparison of Meishan and European breed pigs
[15]. These results are difficult to interpret, primarily
because it is not clear whether the blood vessels adja-
cent to the bilayer were measured preferentially or
whether all placental vessels were included. Because
the epithelial bilayer is the interactive surface between
the dam and fetus and solute diffusion decreases
rapidly with increased distance, only the capillaries directly
adjacent to the bilayer are relevant to nutrient transport.
Finally, placental expression of vascular endothelial growthilayer during gestation. On day 60 of pregnancy (a) the folded
stromal covering of the folds is relatively deep. The fetal placental
ll columnar in appearance, the sides and bottoms are lined with
more complex and has secondary folds, which increases the interacting
tance solutes must diffuse. The stromal space between the folds
e folds is thinner and can be absent in placenta of small fetuses.
epithelial cells within the folded structure and are arranged in a
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reported to increase with advancing gestation and is also
correlated with the fetal weight to placental weight ratio
[31,32]. These results suggest that fetal placental angiogen-
esis may contribute to placental efficiency.
Leiser and Dantzer [33] used microcast techniques to
visualize maternal and fetal capillaries and concluded
that they were arranged in a cross-countercurrent fash-
ion on opposite sides of and directly adjacent to the epi-
thelial bilayer. According to Leiser and Dantzer [33],
maternal blood enters the structure at the top of the
folds and exits at the bottom (fetal side of the placenta is
“up”), fetal blood enters near the bottom of the folds and
exits at the top. Thus, the capillary arrangement ex-
changes solutes between the dam and fetus within the
axis perpendicular to the surface of the placenta. The
distance of the interacting surface along this axis (the
width of the folds) should affect efficiency of exchange,
because a greater width would increase the interaction
distance between the two blood supplies and facilitate
exchange.
Vallet and Freking [20] measured this width through-
out gestation and compared placenta associated with the
largest and smallest fetuses in litters from UHO gilts.
Fold width increased during late gestation, and was
greater in the placenta of small fetuses compared to
large fetuses. In the same experiment, the width of the
stromal area between the top of the folds and the allan-
tois was also measured. This region may represent fur-
ther room for the width of the folds to expand. The
width of this stromal region became progressively less
with advancing gestation, and was less in the placenta of
small fetuses compared to large fetuses. In placenta of
some of the smallest fetuses, a stromal region above the
folds was absent, suggesting that no further expansion of
the folded bilayer was possible.
Given these results, we have hypothesized that expan-
sion of the width of the folds represents a compensatory
mechanism for increasing placental efficiency if the size
of the placenta is restricted (e.g., during intrauterine
crowding). If expansion of the folds exceeds the available
placental stromal width, further compensation is not
possible and fetal growth and development are impaired.
If this impairment is severe enough, the fetus is lost,
contributing to late gestation loss that occurs during
intrauterine crowding.
If this hypothesis is true, one strategy for improving
litter size would be to focus on mechanisms of placental
stroma and folded bilayer development. Stromal tissues
are made up of fibroblasts embedded in extracellular
matrix, large constituents of which are glycosaminoglycans
like hyaluronan and heparan sulfate [34,35]. Glycosamino-
glycans are polymers of sugar [36,37], probably originating
primarily from glucose transported from dam to fetus.Thus, adequate stromal development, and therefore ultim-
ately placental compensatory development, is likely to be
dependent on adequate glucose transport. Logically, this
suggests that placental development and fetal development
compete for glucose resources. This is consistent with re-
ports in sheep where the placenta consumes 60% of incom-
ing glucose [38]. This competition is likely to be most
severe during late gestation and suggests there may be
mechanisms that regulate whether glucose is directed to ei-
ther fetal or placental development.
One such mechanism might be generation of fructose.
Livestock conceptuses are fructogenic [39], meaning that
a substantial portion of incoming glucose is converted to
fructose, primarily by the placenta [40]. Studies indicate
that fructose is oxidized to CO2 at 20% the rate of glu-
cose, so once glucose is converted to fructose it is rela-
tively less available for oxidation [41,42]. Fructose is an
intermediate in glucosamine synthesis and glucosamine
is needed for glycosaminoglycan production [43]. Also
of interest, conversion of fructose to glucosamine stimu-
lates mTOR and regulates cell proliferation in porcine
and human trophoblast cells, tying fructose to placental
development [44,45]. We recently compared glucose and
fructose concentrations in the blood of fetuses from
UHO gilts during late gestation. Neither sugar was re-
lated to fetal weight despite large differences (weight
range 423 to 1473 g). Glucose concentrations were posi-
tively correlated with placental weight (P <0.05; weight
range 73 to 413 g), but fructose concentrations were not
(Vallet, unpublished observations). This suggests that
the concentration of fructose is likely to be regulated
within the conceptus. Whether fructose is synthesized to
sequester it from oxidation and preserve its use for gly-
cosaminoglycan synthesis, or for some other role in me-
tabolism, requires further study.
Factors that control folded bilayer development are
largely unknown. Two types of placental trophoblast
cells are present within the folded bilayer, tall columnar
cells at the tops of the folds and cuboidal cells at the
bottom and sides of the folds. The location of the tall
columnar cells at the top of the folds suggested that they
might play a role in widening of the folded structure by
erosion of the surrounding stroma. To begin to address
the control of fold development, enzymes that degrade
extracellular matrix components of the stroma, which
would be needed to alter bilayer structure, were exam-
ined in the placenta throughout gestation. The cDNAs
corresponding to two forms of hyaluronidase were
cloned from placental tissue. Similarly, two molecular
weight forms of hyaluronidase were detectable in pla-
cental tissue extracts using zymography [35], but the
correspondence between the cDNAs and molecular
weight forms of the proteins has not been fully clarified.
Both protein forms increased with advancing gestation
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consistent with a role for these enzymes in fold forma-
tion. In addition to hyaluronidase, heparanase was also
cloned from placental tissues and expression was exam-
ined using in situ hybridization [46]. Heparanase mRNA
was localized to trophoblast cells lining the sides and
bottom of the folded bilayer, no labeling was observed in
trophoblast cells at the tops of the folds. Heparanase
plays a role in modifications of the basement membrane
during cell movements within tissues [47]. Thus, con-
trary to our hypothesis, the heparanase results suggest
that modifications of the folded bilayer occur along the
sides and bottoms of the folds.
To gain further insight into the role of the two tropho-
blast cell types in fold development, we performed a
transcriptomic analysis of the two cell types that had
been collected from average weight fetuses on day 85 of
gestation [48] using laser capture microdissection com-
bined with high-throughput Illumina sequencing of
cDNA (gestation length in the pig is 114 days). Expres-
sion levels of 7413 genes were observed by the two cell
types combined. Increased expression of 434 genes were
observed for tall columnar trophoblast cells compared to
cuboidal trophoblast cells, while the expression of 1088
genes were greater in cuboidal trophoblast cells com-
pared to tall columnar cells. Ingenuity Pathway Analysis
was used to determine biological pathways that would
be affected by these changes in transcription. Of rele-
vance to fold development, pathways involved in cell in-
vasion, motility and movement were increased in the
cuboidal cells lining the sides and bottom of the folds
compared to tall columnar cells at the tops of the folds.
Heparanase sequences were observed in this analysis,
and preferential transcription of heparanase in cuboidal
cells compared to tall columnar cells was confirmed.
These results again suggest that fold development, or at
least modifications of the morphology of the epithelial
bilayer, is controlled by changes in the sides and bottom
of the folds.
Nutrient specific mechanisms
Most nutrients transported from the dam to the fetus
have specific mechanisms that facilitate transfer. Oxygen
and CO2 cross the bilayer by simple diffusion, but
hemoglobin [49] and carbonic anhydrase [50] facilitate
transport, respectively. Glucose and amino acids are
polar molecules that do not cross cell membranes easily,
and various proteins facilitate their uptake by cells. Very
little is known regarding the specifics of lipid transport.
One report indicated that transport of fatty acid across
the pig placenta is very poor [51]. Vitamin and mineral
transport is facilitated in a variety of ways. For example,
iron in the form of uteroferrin is secreted by the uterine
glands as a component of histotroph, which is thentaken up by placental epithelial cells within the areolae
by pinocytosis [26]. Histotroph is likely to be a vehicle
for the transfer of a variety of nutrients in a similar fash-
ion. An example of a nutrient specific mechanism that
facilitates vitamin transport are placental folate binding
proteins [52,53], which likely mediate folate transport to
the developing conceptus.
Our transcriptomic analysis of placental trophoblast
cells presented an opportunity to survey genes involved
in nutrient transport. To gain further information on
transport mechanisms, we focused attention on solute
carrier (SLC) genes expressed by the two different types
of trophoblast cells. Swine genome 9.2, the version of
the genome used for matching of transcriptomic se-
quences, included 239 SLC genes. This only included
SLC genes placed in the completed sequence, and does
not include all known SLC genes (e.g., notably absent
are SLC2 sugar transporter genes SLC2A1, 2, 3, 5, 6, 9
and 11). In addition to this limitation, only genes with
average expression between the two cell types of greater
than 1.8 fragments per kilobase of exon model mapped
per million mapped reads (FPKM) were considered to
be present in the cells [48] (Table 1). Nevertheless, the
results provide information on an extensive list of SLC
genes expressed by trophoblast cells, and indicate that
numerous genes for glucose, amino acid, lipid, vitamin
and mineral transport proteins are expressed by placen-
tal trophoblast cells.
One final caveat regarding these results is that al-
though SLC genes are all involved in solute transport
across membranes, not all are involved in nutrient trans-
port across the plasma membrane, which would be
required for a role in transport between the dam and
fetus. Many are involved in transport between organelles
within cells (e.g., SLC25 genes are all mitochondrial
transport genes). Some provide substrate influx into the
cell, while others provide substrate efflux, and some do
both depending on their cellular location (e.g., apical vs.
basal) and the conditions in and around the cell. Because
two epithelial cell layers separate maternal and fetal
blood in the pig, all nutrients must pass four intact cell
membranes to reach the fetal blood, so whether they
participate in influx or efflux, they would still contribute
to nutrient transport to the fetus. Despite these limita-
tions, the results provide suggestions for future experi-
ments that could be directed at understanding the
transport of nutrients and the physiology of the pig
placenta.
General
Of the 293 SLC genes in the Swine Genome build 9.2,
108 genes (37% of total) had expression values greater
than 1.8 PKM. Of these, the expression of 30 (28% of
expressed) were greater in short cuboidal compared to
Table 1 Expression (FPKM) of SLC genes by short cuboidal and tall columnar trophoblast epithelial cells (see Figure 2)
from pig placenta collected on day 85 of gestation by laser capture microdissection (n = 4 pigs)






SLC1A3 Amino Acid solute carrier family 1 (glial high affinity glutamate transporter), member 3 0.008342 103.518 152.46*
SLC1A5 Amino Acid solute carrier family 1 (neutral amino acid transporter), member 5 0.005574 19.865 29.593*
SLC2A10 Glucose solute carrier family 2 (facilitated glucose transporter), member 10 0.356081 1.774 2.437
SLC2A12 Glucose solute carrier family 2 (facilitated glucose transporter), member 12 0.019601 93.214 124.979*
SLC2A13 Inositol solute carrier family 2 (facilitated glucose transporter), member 13 0.012995 38.491* 26.879
SLC2A4 Glucose solute carrier family 2 (facilitated glucose transporter), member 4 0.04111 3.39* 2.185
SLC3A1 Amino Acid solute carrier family 3 (cystine, dibasic and neutral amino acid transporters,
activator of cystine, dibasic and neutral amino acid transport), member 1
0.676755 29.255 28.814
SLC4A1AP None solute carrier family 4 (anion exchanger), member 1, adaptor protein 0.510953 3.625 3.356
SLC4A4 Bicarbonate solute carrier family 4, sodium bicarbonate cotransporter, member 4 0.40478 3.657 2.806
SLC4A7 Bicarbonate solute carrier family 4, sodium bicarbonate cotransporter, member 7 0.0625 3.787 2.531
SLC5A6 Vitamins solute carrier family 5 (sodium-dependent vitamin transporter), member 6 2.08E-05 27.352* 7.827
SLC6A6 Amino Acid solute carrier family 6 (neurotransmitter transporter, taurine), member 6 0.700481 3.691 4.132
SLC6A8 Creatine solute carrier family 6 (neurotransmitter transporter, creatine), member 8 0.0925 3.97 2.598
SLC7A2 Amino Acid solute carrier family 7 (cationic amino acid transporter, y + system), member 2 0.35208 2.194 1.559
SLC7A4 Amino Acid? solute carrier family 7 (orphan transporter), member 4 0.612879 101.015 99.302
SLC7A7 Amino Acid solute carrier family 7 (amino acid transporter light chain, y + L system), member 7 0.048306 3.179* 2.013
SLC7A8 Amino Acid solute carrier family 7 (amino acid transporter light chain, L system), member 8 0.092703 6.23 4.956
SLC7A9 Amino Acid solute carrier family 7 (glycoprotein-associated amino acid transporter light
chain, bo,+ system), member 9
0.004643 2.419* 4.289
SLC9A1 Na+/H+ solute carrier family 9, subfamily A (NHE1, cation proton antiporter 1), member 1 0.462724 2.827 3.147
SLC9A3R1 Na+/H+ solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member
3 regulator 1
4.51E-05 22.04* 10.738
SLC9A6 Na+/H+ solute carrier family 9, subfamily A (NHE6, cation proton antiporter 6), member 6 0.577227 3.025 3.173
SLC9A8 Na+/H+ solute carrier family 9, subfamily A (NHE8, cation proton antiporter 8), member 8 0.195039 5.92 4.937
SLC9A9 Na+/H+ solute carrier family 9, subfamily A (NHE9, cation proton antiporter 9), member 9 0.109026 4.589 6.648
SLC10A7 steroids solute carrier family 10 (sodium/bile acid cotransporter family), member 7 0.226002 2.569 3.55
SLC12A6 K+/Cl- solute carrier family 12 (potassium/chloride transporters), member 6 0.717437 6.458 6.382
SLC13A3 Dicarboxylate solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3 0.004193 19.292* 28.657
SLC13A4 Sulfate solute carrier family 13 (sodium/sulfate symporters), member 4 1.73E-06 91.288* 44.882
SLC14A1 Urea solute carrier family 14 (urea transporter), member 1 (Kidd blood group) 0.579099 3.759 5.211
SLC15A1 Di/tripeptides solute carrier family 15 (oligopeptide transporter), member 1 0.10901 2.251 1.715
SLC15A2 Di/tripeptides solute carrier family 15 (H+/peptide transporter), member 2 6.49E-05 84.452 147.72*
SLC16A10 Amino Acid solute carrier family 16, member 10 (aromatic amino acid transporter) 0.057011 47.966 38.846
SLC16A12 Creatine solute carrier family 16, member 12 (monocarboxylic acid transporter 12) 5.09E-05 7.95* 2.177
SLC16A14 ? solute carrier family 16, member 14 (monocarboxylic acid transporter 14) 0.002365 9.309* 5.651
SLC16A7 Lactate solute carrier family 16, member 7 (monocarboxylic acid transporter 2) 0.01361 3.627* 1.939
SLC16A9 Urate solute carrier family 16, member 9 (monocarboxylic acid transporter 9) 0.348855 3.476 2.655
SLC17A5 Acid sugars solute carrier family 17 (anion/sugar transporter), member 5 0.627423 7.041 7.408
SLC19A2 Thiamine solute carrier family 19 (thiamine transporter), member 2 0.009728 3.455* 2.193
SLC20A1 Phosphate solute carrier family 20 (phosphate transporter), member 1 0.003578 8.612* 4.872
SLC22A18 Organic cations solute carrier family 22, member 18 0.12071 2.883 1.365
SLC22A23 ? solute carrier family 22, member 23 0.396248 3.315 3.06
SLC22A3 Polyamines solute carrier family 22 (extraneuronal monoamine transporter), member 3 0.000145 3.563* 0.81
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Table 1 Expression (FPKM) of SLC genes by short cuboidal and tall columnar trophoblast epithelial cells (see Figure 2)
from pig placenta collected on day 85 of gestation by laser capture microdissection (n = 4 pigs) (Continued)
SLC25A1 Mitochondrial
citrate, malate




solute carrier family 25 (mitochondrial carrier; oxoglutarate carrier), member 11 0.108779 5.333 3.636
SLC25A12 Mitochondrial
Amino Acid
solute carrier family 25 (aspartate/glutamate carrier), member 12 0.131405 7.194 5.996
SLC25A13 Mitochondrial
Amino Acid
solute carrier family 25 (aspartate/glutamate carrier), member 13 0.409356 17.13 15.642
SLC25A14 Mitochondrial H+
(uncoupling)
solute carrier family 25 (mitochondrial carrier, brain), member 14 0.706134 1.957 2.11
SLC25A17 Mitochondrial CoA,
FAD
solute carrier family 25 (mitochondrial carrier; peroxisomal membrane protein,




solute carrier family 25 (carnitine/acylcarnitine translocase), member 20 0.536736 18.412 20.059
SLC25A24 Mitochondrial ATP solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 24 0.345305 12.014 10.704




solute carrier family 25 (S-adenosylmethionine carrier), member 26 0.458853 1.883 1.809
SLC25A27 Mitochondrial H+
(uncoupling)
solute carrier family 25, member 27 0.050934 3.482* 2.227
SLC25A28 Mitochondrial iron solute carrier family 25 (mitochondrial iron transporter), member 28 0.398812 2.266 1.939
SLC25A3 Mitochondrial
phosphate
solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 3 0.465844 207.118 195.026
SLC25A32 Mitochondrial
folate
solute carrier family 25 (mitochondrial folate carrier), member 32 0.342663 2.325 3.289
SLC25A33 Mitochondrial UTP solute carrier family 25 (pyrimidine nucleotide carrier), member 33 0.02715 3.591* 1.889
SLC25A36 Mitochondrial UTP solute carrier family 25 (pyrimidine nucleotide carrier), member 36 0.479823 10.419 11.013
SLC25A37 Mitochondrial iron solute carrier family 25 (mitochondrial iron transporter), member 37 0.684822 8.405 8.581
SLC25A43 Mitochondrial ? solute carrier family 25, member 43 0.004424 2.411 4.746*
SLC25A44 Mitochondrial ? solute carrier family 25, member 44 0.660881 4.946 5.013
SLC25A46 Mitochondrial ? solute carrier family 25, member 46 0.714232 3.622 4.053
SLC25A5 Mitochondrial ADP,
ATP





solute carrier family 26 (sulfate transporter), member 2 0.002566 18.742* 9.657
SLC27A4 Long chain fatty
acids
solute carrier family 27 (fatty acid transporter), member 4 0.718866 2.528 2.328
SLC27A6 Long chain fatty
acids
solute carrier family 27 (fatty acid transporter), member 6 0.001938 5.536* 1.159
SLC29A1 Nucleosides solute carrier family 29 (nucleoside transporters), member 1 0.002403 51.871* 28.705
SLC29A3 Nucleosides solute carrier family 29 (nucleoside transporters), member 3 0.0282 4.818* 3.052
SLC30A4 Zinc solute carrier family 30 (zinc transporter), member 4 0.137271 2.308 1.538
SLC30A6 Zinc solute carrier family 30 (zinc transporter), member 6 0.544857 6.784 6.425
SLC30A7 Zinc solute carrier family 30 (zinc transporter), member 7 0.606204 10.946 11.388
SLC30A9 Zinc solute carrier family 30 (zinc transporter), member 9 0.040343 12.638* 9.474
SLC31A2 Copper solute carrier family 31 (copper transporters), member 2 0.692963 3.737 4.636
SLC35A1 Nucleotide sugar solute carrier family 35 (CMP-sialic acid transporter), member A1 0.001966 8.876* 3.703
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Table 1 Expression (FPKM) of SLC genes by short cuboidal and tall columnar trophoblast epithelial cells (see Figure 2)
from pig placenta collected on day 85 of gestation by laser capture microdissection (n = 4 pigs) (Continued)
SLC35A3 Nucleotide sugar? solute carrier family 35 (UDP-N-acetylglucosamine (UDP-GlcNAc) transporter),
member A3
0.003442 19.107 33.186*
SLC35A4 Nucleotide sugar? solute carrier family 35, member A4 0.717081 2.659 2.795
SLC35A5 Nucleotide sugar? solute carrier family 35, member A5 0.683471 5.015 5.377
SLC35B1 Adenosine
phospho-sulfate
solute carrier family 35, member B1 0.347209 14.398 13.503
SLC35B2 Adenosine
phospho-sulfate
solute carrier family 35, member B2 0.53865 2.75 2.625
SLC35B3 Adenosine
phospho-sulfate
solute carrier family 35, member B3 0.353606 6.322 5.239
SLC35C1 Nucleotide sugar solute carrier family 35, member C1 0.00016 19.1* 6.88
SLC35D1 Nucleotide sugar solute carrier family 35 (UDP-glucuronic acid/UDP-N-acetylgalactosamine dual
transporter), member D1
0.688317 3.286 2.87
SLC35E1 ? solute carrier family 35, member E1 0.066081 4.953 2.826
SLC35E3 ? solute carrier family 35, member E3 0.265752 2.049 1.612
SLC35F2 ? solute carrier family 35, member F2 0.10158 3.188 2.186
SLC35F5 ? solute carrier family 35, member F5 0.289527 22.192 24.888
SLC36A1 Amino acid solute carrier family 36 (proton/amino acid symporter), member 1 0.157349 19.844 16.848
SLC36A4 Amino acid solute carrier family 36 (proton/amino acid symporter), member 4 0.159179 2.836 1.761
SLC37A1 Sugar phosphate solute carrier family 37 (glycerol-3-phosphate transporter), member 1 0.000295 3.492* 1.626
SLC37A4 Sugar phosphate solute carrier family 37 (glucose-6-phosphate transporter), member 4 0.196418 6.082 5.027
SLC38A1 Amino acid solute carrier family 38, member 1 0.023371 11.839* 9.529
SLC38A6 Amino acid? solute carrier family 38, member 6 0.00099 3.834 7.593*
SLC38A7 Glutamine solute carrier family 38, member 7 0.657535 2.284 2.435
SLC38A9 Amino acid? solute carrier family 38, member 9 0.203752 4.997 3.792
SLC39A11 Zinc solute carrier family 39 (metal ion transporter), member 11 0.519439 18.918 20.158
SLC39A14 Zinc, iron,
cadmium
solute carrier family 39 (zinc transporter), member 14 5.13E-05 19.797* 8.718
SLC39A7 Zinc solute carrier family 39 (zinc transporter), member 7 0.644212 9.946 10.299
SLC39A8 Zinc, cadmium solute carrier family 39 (zinc transporter), member 8 0.219082 6.948 4.375
SLC39A9 Zinc solute carrier family 39 (zinc transporter), member 9 0.029289 12.607* 8.939
SLC44A1 Choline solute carrier family 44, member 1 0.004045 29.547 45.151*
SLC44A2 Choline solute carrier family 44, member 2 0.502802 22.687 21.741
SLC44A3 Choline? solute carrier family 44, member 3 0.014683 6.273 10.268*
SLC44A4 Thiamine pyro-
phosphate, choline
solute carrier family 44, member 4 0.002671 6.012* 2.58
SLC46A3 Folate? solute carrier family 46, member 3 0.208452 4.484 3.561
SLC47A1 Organic cations
(e.g. creatinine)
solute carrier family 47, member 1 0.645687 2.158 2.886
SLC47A2 Organic cations
(e.g. creatinine)
solute carrier family 47, member 2 0.60417 3.179 2.282
SLCO2A1 Prostaglandins solute carrier organic anion transporter family, member 2A1 0.000609 70.11 123.911*
SLCO2B1 Steroids,
prostaglandins
solute carrier organic anion transporter family, member 2B1 0.004457 3.665* 2.195
SLCO4C1 thyroxin solute carrier organic anion transporter family, member 4C1 1.95E-05 68.57* 36.456
*Asterisk indicates greater expression in cell type indicated (P<0.05).
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http://www.jasbsci.com/content/5/1/55tall columnar cells, and 10 (9% of expressed) were greater
in tall columnar cells compared to short cuboidal cells. This
compares to 20,461 genes in Swine Genome build 9.2;
7,413 (36% of total) genes expressed by trophoblast cells,
and 1,088 genes (15% of expressed) greater in short
cuboidal and 434 genes (6% of expressed) greater in tall col-
umnar cells. Thus, transport genes do not appear to be
preferentially expressed by trophoblast cells as a group
compared to all genes, but preferential expression of SLC
genes by short cuboidal cells appears to be greater generally
than tall columnar cells, and greater than the frequency of
preferential expression of all genes by short cuboidal cells.
This may suggest that nutrient transport occurs preferen-
tially through short cubiodal trophoblast cells, which is also
consistent with their small size and greater surface area
relative to tall columnar cells.
Sugars
Sugars are polar molecules, and their transport is medi-
ated by specific proteins, facilitative glucose transporters
(GLUT) and Na-dependent glucose transporters (SGLT),
which are involved in passive and active transport of
glucose, respectively [54]. SLC2 and SLC5 genes, re-
spectively, correspond to these two types of trans-
porters [55,56]. Sequences matching SLC2A7 were not
observed. The two most highly expressed SLC2 genes
were SLC2A12 and 13, corresponding to GLUT12 and
proton-dependent inositol transporter, respectively.
SLC2A4 and 10 (GLUT4 and 10) were also observed.
SLC2A12 expression was greater in tall columnar cells
compared to cuboidal cells, while the reverse was true for
SLC2A13. GLUT12 and GLUT4 are insulin dependent
glucose transporters [57], but levels of insulin are reported
to be very low in the pig fetus [39]. However, insulin like
growth factors (IGF) can also regulate GLUT4 trans-
porters [58] (similar results are not available for GLUT12),
suggesting that IGF1 and 2 may provide regulation of glu-
cose transport to the pig conceptus via changes in GLUT4
and GLUT12. Also, the high expression and increased
presence of GLUT12 in tall columnar trophoblast cells
suggest that these cells may be specialized to provide a
regulatory role for placental function through regulation
of glucose transport.
The second highest SLC2 gene expressed by placenta,
SLC2A13, corresponds to proton-dependent inositol
transporter, which is an inositol-H+ cotransporter that
follows a proton gradient and therefore represents active
transport for inositol [59,60]. The high expression of this
active transporter suggests (1) that inositol has an im-
portant role in some aspect of conceptus development
or function and (2) that transport of inositol would be
encouraged by acidic conditions within the placenta.
Consistent with an important role for inositol, concen-
trations in the fetus are unusually high (4-5 mmol/L,rivaling fructose), and are greater in small fetuses com-
pared to large fetuses [61,62]. Phospholipids containing
inositol, and inositol phosphates derived from them, are
second messengers for a variety of receptor systems [63].
Inositol containing lipids also participate in cell mem-
brane fusions required for trafficking of cell membrane
components [64]. In addition, many membrane proteins
are anchored to the cell membrane through glycopho-
sphatidylinositol linkages [65]. Although these second
messenger systems and other biochemical processes that
require inositol are vital, they are unlikely to require trans-
port of large amounts and high concentrations of inositol.
Inositol can also be converted to glucuronic acid through
the action of myo-inositol oxygenase (MIOX) [66]. Se-
quences matching the MIOX gene were found in tropho-
blast cells, and were greater in the short cuboidal cells
similar to the SLC2A13 sequences. Glucuronic acid is a
component of hyaluronan, but mammals like the pig
apparently lack the enzymes necessary to generate
UDP-glucuronate from glucuronic acid [67], instead
UDP-glucuronate is generated using UDP-glucose as a
substrate. Free glucuronic acid can be metabolized to
CO2 in the pentose shunt pathway, so it could be used
for energy. Alternatively, glucuronate is also a sub-
strate for the generation of ascorbic acid [68]. Ascor-
bic acid is one of the main antioxidants available to
tissues to prevent oxidative damage from free radicals.
Ascorbic acid is also required to transfer the iron con-
tained in uteroferrin to transferrin [69]. Whether inosi-
tol is used for inositol lipids and second messengers,
glucuronic acid, ascorbic acid or energy generation in
conceptus development will require further study.
Amino acids
A number of SLC genes are known transporters of amino
acids including members of the SLC1, SLC3, SLC6, SLC7,
SLC16, SLC36 and SLC38 gene families [70-76] (Table 1).
Of these, the three most highly expressed were SLC1A3,
SLC7A4 and SLC16A10. The SLC1A3 gene codes for a
glutamate/aspartate transport protein [74] (GLAST). In
the brain, this protein is responsible for removal of glu-
tamate, a potent neurotransmitter, from the synaptic space
of glutamate releasing neurons. Glutamate is taken up by
astrocytes and rapidly converted to glutamine, which is
then released back to the neurons for reuptake and syn-
thesis of glutamate. Interestingly, our results indicate that
glutamine synthetase is highly expressed by both types of
trophoblast cells (GLUL, short cuboidal cells 328.9 FPKM,
tall columnar cells 388.2 FPKM), suggesting that some
portion of glutamate transported into cells is likely to be
converted to glutamine. Consistent with this, the glutam-
ine concentration in fetal plasma was greatest of all the
amino acids throughout most of gestation, and was much
higher than maternal plasma levels [77,78]. As previously
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along with fructose, providing substrate for hyaluronan
and other glycosamine glycans, and glucosamine synthesis
is known to be tied to mTOR control of proliferation of
day 12 trophoblast cells [44,45]. Thus, it seems possible
that glutamine and fructose combine to provide overall
regulation of placental development, through generation
of glycosaminoglycans and control of proliferation of
trophoblast cells.
SLC7A4 codes for the CAT-4 protein, which is related
to the other members of SLC7 family of cationic amino
acid transporter. Proteins encoded by the SLC7A1, 2
and 3 genes are membrane proteins that transport
lysine, arginine and ornithine, and correspond to the
y+ amino acid transport system. However, the CAT-4
protein apparently has no intrinsic transporter activity
[76], so its function is not clear. Supplemental arginine
is known to increase litter size, possibly through its role
in NO synthesis [79,80]. However, because it is not clear
what role the SLC7A4 gene has in cationic amino acid
transport or metabolism, its role in arginine metabolism
is also unclear.
The SLC16A10 gene encodes the MCT10 protein, an
aromatic amino acid transporter [71]. Three of the four
aromatic amino acids are nutritionally essential (histi-
dine, tryptophan, phenylalanine), while the fourth (tyro-
sine) can be synthesized from phenyalanine. The high
expression of this gene may be related to the fact that
most of the transported amino acids cannot be synthe-
sized by the fetus. In addition, the MCT10 protein is not
Na+ or H+ coupled, so transport relies on the concen-
tration gradient for these amino acids. The concentra-
tions of all four amino acids in maternal and fetal
plasma throughout gestation are consistent with passive
transport as the mechanism of transport (fetal concen-
tration is lower than maternal) [77]. If the high expres-
sion of the gene is related to the essential nature of the
amino acids and the passivity of transport, it suggests
that transport of these amino acids might be particularly
sensitive to factors that impair SLC16A10 expression or
mRNA translation, or factors that result in reduced con-
centrations of aromatic amino acids in the maternal
blood (e.g. shortages in the diet).
Curiously, trophoblast cells highly express the SLC15A2
gene, which is a di/tripeptide transporter [81]. This sug-
gests an alternative route of amino acid absorption by
the placenta, via absorption of di- and tri-peptides, even
though low levels of these are likely to be circulating in
maternal blood. Alternatively, this transporter could func-
tion to allow transport of specific di- and tripeptides, such
as carnosine and glutathione, respectively. Both provide
antioxidant activity, which may be important in protecting
the fetus from free radicals generated during respiration.
Whether significant amino acids are transported to theplacenta as di- and tri-peptides, or whether the SLC15A2
gene serves another role in conceptus metabolism will re-
quire further study.
Lipids
Of the SLC genes found to be expressed by trophoblast
cells, only SLC27A4 and SLC27A6 transport lipids in
the form of long chain fatty acids [82,83]. Neither of
these genes is highly expressed by trophoblast cells
(Table 1), which is consistent with previous reports indi-
cating very poor transport of fatty acids by pig placenta
[51]. Alternatively, lipids could be transported to the de-
veloping conceptus in the form of triglycerides associ-
ated with lipoproteins. Although they are not SLC genes,
receptors for lipoprotein complexes are expressed by
trophoblast cells, with the greatest being LRP6 (SC cells
10.9, TC cells 8.8 FPKM; McNeel et al., unpublished ob-
servations) [84]. Thus, it is likely that lipids reach the
conceptus through two mechanisms, transport as free
fatty acids, which appears likely to be poor, and as lipids
associated with lipoproteins.
Vitamins
Vitamins are transported by SLC5A6 (biotin, pantothe-
nic acid) [85], SLC19A2 (thiamine) [86], SLC25A32
(mitochondrial folate) [87], SLC44A1, 2 and 3 (choline)
and SLC44A4 (thiamine) [88] and SLC46A3 (folate) [86].
The two most highly expressed are SLC5A6 and SLC44A1.
SLC5A6 is a multivitamin transporter, and the high expres-
sion is likely to be related to the essential nature of these
vitamins as cofactors in metabolic reactions. High expres-
sion of SLC44A1 (and SLC44A2) suggests that high levels
of choline are needed for some aspect of fetal development.
Choline is a component of choline containing phospho-
lipids (phosphatidylcholine and sphingomyelin), which
themselves are components of cell membranes. Also,
choline is a component of the neurotransmitter acetyl-
choline. Finally, choline is a source of methyl groups
for methylation reactions [89]. Methylations are particu-
larly important for placental function, as many imprinted
genes that influence placental function are controlled by
differential methylation of gene copies originating from
either the sire or the dam [90].
Minerals
Zinc is transported by SLC30A4, A6, A7, and A9, and
SLC39A7, 8, 9, 11, and 14 [91-93]. The combined ex-
pression of these genes suggests that zinc is very import-
ant to the physiology and biochemistry of the fetus. Zinc
participates in a variety of biochemical reactions, includ-
ing antioxidant activity (superoxide dismutase) and pros-
taglandin synthesis [94-96]. But the most important to
the fetus is likely to be its incorporation into carbonic
anhydrase, which plays a role in metabolism of CO2
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bonate ion from CO2, and is a major mechanism enab-
ling the safe transport in serum of CO2 away from
tissues after it is produced. Interestingly, a recent study
indicated that supplementation of zinc during late preg-
nancy reduced the incidence of stillbirths in low birth
weight piglets, reinforcing the importance of zinc to the
developing pig fetus [97].
Other minerals are also transported by SLC genes
[87,98-101], specifically iron (SLC25A28 and A37, both
mitochondrial), copper (SLC31A2), sulfate (SLC13A4,
SLC26 A2) and phosphate (SLC20A1, mitochondrial
SLC25A3). Transport by these SLC genes likely sup-
port heme production for respiratory chain enzymes,
copper containing superoxide dismutase and other
copper containing proteins, sulfation of proteoglycans
and organic compounds and myriad phosphorylation
reactions.
Hormones
Although not nutrients, transport of hormones in and
out of trophoblast cells is likely to have important effects
on placental function in an autocrine and paracrine
manner, and on the fetus in an endocrine manner. SLC
genes [102,103] participate in transport of prostaglandins
(SLCO21A1), steroids (SLC10A7, SLCO2B1) and thyroid
hormones (SLCO4C1). Secretion of prostaglandins by
the placenta are key regulators of the initiation of far-
rowing [104] and probably also participate in the control
of blood flow. Placental tissues secrete large amounts of
estrogen [105,106], which likely plays a role in mammary
gland development during pregnancy. The role of thy-
roid hormones in the placenta is less clear, but the
expression level of the SLCO4C1 gene suggests that fur-
ther work may be warranted to understand how thyroid
hormones may regulate placental function or fetal devel-
opment in pigs.
Summary
The pig placenta mediates nutrient transport between
the dam and the developing pig fetus. Physical characteris-
tics and the expression of nutrient specific mechanisms of
the placenta combine to determine the efficiency of trans-
port of the various nutrients required for the development
of a healthy piglet at birth. Further work is needed to
understand and enhance the development of the folded
epithelial bilayer of the pig placenta. Clues to important
transport mechanisms for the pig placenta are found in
the expression levels of various genes, but further work is
needed to confirm the roles of these genes in transport
and suggest dietary or management strategies that will im-
prove the transport of specific nutrients to the developing
pig fetus. It is still unclear what nutrients currently limit
fetal development in the pig.Conclusions
We are only beginning to understand the physiological
mechanisms that control the morphology and nutrient
transport capability of the pig placenta, but it is likely
that further understanding will allow not only improve-
ments in litter size, but also reduction of stillbirth and
preweaning mortality. Inefficiencies in placental function
during gestation are likely to be a primary contributor to
perinatal and neonatal piglet losses, as well as the num-
ber of fully formed fetuses at farrowing.
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